LMAT
LeMaitre Vascular, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Sell
-25/100
Last price
79.23
▼ 1.76 (2.17%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
80.01
Prev close
80.99
Day high
81.13
Day low
78.90
Volume
283.35K
Market cap
$1.81B
P/E (TTM)
28.44
52W range
78.22 – 118.01
Day trading desk
Gap from prior close
-1.21%
Prior close 80.99
VWAP
79.41
-0.22% from price
Relative volume
1.22×
Normal
Session range
3.06%
78.90 – 81.31
Position in range
14%
Near session low
ATR (14D)
2.04
2.58% of price
Prior day high
81.83
PDH
Prior day low
78.49
PDL
Bid / ask spread
—
Quote not published
Session volume
404.54K
Avg 331.72K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.63%
-6.6%
1M
-2.01%
-3.2%
3M
-22.36%
-26.9%
6M
-28.35%
-46.5%
YTD
-2.53%
-16.8%
1Y
-10.02%
-26.4%
3Y
+45.10%
-37.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LMAT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-17.23K
Net selling
Buy transactions
6
38.23K shares
Sell transactions
3
55.47K shares
Net transactions
+9
Buys less sells
Sell : buy shares
1.5 : 1
Mixed
Insider-held shares
1.49M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 1, 26 | ROUSH JOHN ADAM Director |
CONVERSION | 3.44K | $167.38K | Direct |
| Jun 4, 26 | LEMAITRE GEORGE W Chief Executive Officer |
STOCK | 11.97K | $0 | Direct |
| Jun 4, 26 | LEMAITRE GEORGE W Chief Executive Officer |
STOCK | 11.97K | $0 | Indirect |
| May 8, 26 | LEMAITRE GEORGE W Chief Executive Officer |
SELL | 46.48K | $5.03M | Direct |
| May 7, 26 | JASINSKI LAWRENCE J Director |
CONVERSION | 2.86K | $188.41K | Direct |
| May 7, 26 | ROSS BRIDGET A. Director |
CONVERSION | 5.04K | $242.88K | Direct |
| May 7, 26 | JASINSKI LAWRENCE J Director |
SELL | 3.94K | $433.73K | Direct |
| May 7, 26 | ROSS BRIDGET A. Director |
SELL | 5.04K | $560.37K | Direct |
| Apr 22, 26 | PELLEGRINO JOSEPH P JR Director |
CONVERSION | 2.94K | $104.35K | Direct |
| Mar 11, 26 | KAMKE TRENT G Officer |
CONVERSION | 2.63K | $93.14K | Direct |
| Mar 11, 26 | KAMKE TRENT G Officer |
SELL | 2.63K | $284.81K | Direct |
| Mar 11, 26 | ROBERTS DAVID BRIAN President |
SELL | 3.31K | $356.59K | Direct |
| Mar 10, 26 | LEBLANC DORIAN PAUL CPA Chief Financial Officer |
— | 2 | — | Direct |
| Mar 2, 26 | LEMAITRE GEORGE W Chief Executive Officer |
SELL | 205.93K | $22.04M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
JASINSKI LAWRENCE J |
Director | 4.71K | Conversion of Exercise of derivative security |
KAMKE TRENT G |
Officer | 6.68K | Conversion of Exercise of derivative security |
LEBLANC DORIAN PAUL CPA |
Chief Financial Officer | 2.30K | Conversion of Exercise of derivative security |
LEMAITRE GEORGE W |
Chief Executive Officer | 1.46M | Stock Gift |
O'CONNOR JOHN JAMES EDWARD |
Director | 62.83K | Conversion of Exercise of derivative security |
PELLEGRINO JOSEPH P JR |
Director | 15.02K | Conversion of Exercise of derivative security |
ROBERTS DAVID BRIAN |
President | 14.67K | Sale |
ROSS BRIDGET A. |
Director | 3.94K | Conversion of Exercise of derivative security |
ROUSH JOHN ADAM |
Director | 7.57K | Conversion of Exercise of derivative security |
SHADAN MARTHA |
Director | 2.96K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.81B
Enterprise value$1.62B
Revenue (TTM)$262.43M
Gross profit$188.60M
EBITDA$83.02M
Net income$65.67M
EPS (TTM)$2.78
Free cash flow$49.26M
Total cash$376.24M
Total debt$190.25M
Book value / share$18.38
Shares outstanding22.87M
Float21.30M
Short % of float9.31%
Dividend yield1.23%
Beta (5Y)0.47
Valuation & profitability ratios
Trailing P/E28.44
Forward P/E24.87
PEG ratio2.15
Price / sales—
Price / book4.30
EV / revenue6.18
EV / EBITDA19.54
Gross margin71.87%
Operating margin28.98%
Profit margin25.02%
Return on equity16.77%
Return on assets7.44%
Debt / equity45.26
Current ratio16.31
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $249.60M | $219.86M | $193.48M | $161.65M | +13.5% |
| Operating revenue | $249.60M | $219.86M | $193.48M | $161.65M | +13.5% |
| Cost of revenue | $71.06M | $68.96M | $66.44M | $56.76M | +3.0% |
| Gross profit | $178.54M | $150.90M | $127.05M | $104.90M | +18.3% |
| Research & development | $14.14M | $15.65M | $16.97M | $13.29M | -9.7% |
| Selling, general & admin | $96.49M | $83.00M | $72.89M | $61.67M | +16.3% |
| Total operating expense | $110.63M | $98.64M | $89.85M | $74.96M | +12.1% |
| Operating income | $67.91M | $52.26M | $37.20M | $29.94M | +30.0% |
| Net interest income | -$5.18M | -$205.00K | $0 | $986.00K | -2,428.8% |
| Pre-tax income | $75.18M | $56.88M | $39.48M | $27.49M | +32.2% |
| Tax provision | $17.45M | $12.84M | $9.37M | $6.85M | +35.9% |
| Net income | $57.73M | $44.04M | $30.11M | $20.64M | +31.1% |
| Net income to common | $57.73M | $44.04M | $30.11M | $20.64M | +31.1% |
| Basic EPS | 2.55 | 1.96 | 1.36 | 0.94 | +30.1% |
| Diluted EPS | 2.52 | 1.93 | 1.34 | 0.93 | +30.6% |
| EBIT | $80.37M | $57.08M | $39.48M | $27.49M | +40.8% |
| EBITDA | $90.79M | $66.69M | $48.99M | $36.92M | +36.1% |
| Basic shares | 22.64M | 22.45M | 22.22M | 21.98M | +0.8% |
| Diluted shares | 22.93M | 22.78M | 22.42M | 22.17M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $28.24M | $25.61M | $24.27M | $19.13M | +10.3% |
| Cash & short-term investments | $359.12M | $299.72M | $105.07M | $82.69M | +19.8% |
| Accounts receivable | $33.61M | $30.06M | $25.06M | $22.04M | +11.8% |
| Inventory | $58.25M | $55.94M | $52.33M | $45.28M | +4.1% |
| Total current assets | $468.23M | $402.19M | $194.60M | $161.73M | +16.4% |
| Property, plant & equipment | $42.76M | $41.57M | $39.78M | $33.53M | +2.9% |
| Goodwill & intangibles | $99.03M | $101.76M | $107.66M | $112.47M | -2.7% |
| Total assets | $615.69M | $551.82M | $346.78M | $310.48M | +11.6% |
| Total current liabilities | $36.32M | $30.61M | $29.88M | $25.33M | +18.7% |
| Long-term debt | $168.65M | $167.77M | — | — | +0.5% |
| Total debt | $185.59M | $185.69M | $19.09M | $16.60M | -0.1% |
| Total liabilities | $222.17M | $214.53M | $48.88M | $42.27M | +3.6% |
| Retained earnings | $184.72M | $145.09M | $115.43M | $97.77M | +27.3% |
| Shareholder equity | $393.52M | $337.29M | $297.90M | $268.20M | +16.7% |
| Working capital | $431.91M | $371.58M | $164.72M | $136.40M | +16.2% |
| Net tangible assets | $294.48M | $235.53M | $190.24M | $155.73M | +25.0% |
| Shares issued | 24.40M | 24.15M | 23.91M | 23.66M | +1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $57.73M | $44.04M | $30.11M | $20.64M | — | +31.1% |
| Depreciation & amortisation | $10.42M | $9.61M | $9.52M | $9.43M | — | +8.4% |
| Stock-based compensation | $7.83M | $6.57M | $5.32M | $4.17M | — | +19.2% |
| Change in working capital | -$1.75M | -$20.10M | -$11.25M | -$13.40M | — | +91.3% |
| Operating cash flow | $81.25M | $44.12M | $36.75M | $25.38M | — | +84.1% |
| Capital expenditure | -$6.78M | -$6.96M | -$7.26M | -$3.23M | — | +2.6% |
| Investing cash flow | -$64.94M | -$200.12M | -$24.71M | -$10.37M | — | +67.5% |
| Share buybacks | — | — | — | -$642.00K | -$802.00K | — |
| Dividends paid | -$18.11M | -$14.38M | -$12.45M | -$10.99M | — | -25.9% |
| Financing cash flow | -$14.54M | $158.10M | -$7.13M | -$9.23M | — | -109.2% |
| Free cash flow | $74.47M | $37.16M | $29.49M | $22.15M | — | +100.4% |
| End cash position | $28.24M | $25.61M | $24.27M | $19.13M | — | +10.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $70.38M | $66.55M | $64.45M | $61.05M | $64.23M | +5.8% |
| Operating revenue | $70.38M | $66.55M | $64.45M | $61.05M | $64.23M | +5.8% |
| Cost of revenue | $19.62M | $18.16M | $18.26M | $15.09M | $19.26M | +8.1% |
| Gross profit | $50.76M | $48.40M | $46.19M | $45.95M | $44.97M | +4.9% |
| Research & development | $4.85M | $4.06M | $3.53M | $2.97M | $3.54M | +19.4% |
| Selling, general & admin | $25.52M | $26.56M | $23.82M | $22.67M | $25.29M | -3.9% |
| Total operating expense | $30.36M | $30.62M | $27.36M | $25.64M | $28.83M | -0.8% |
| Operating income | $20.40M | $17.77M | $18.83M | $20.31M | $16.14M | +14.8% |
| Net interest income | $2.08M | -$1.30M | -$11.04M | $2.57M | $1.68M | +260.3% |
| Pre-tax income | $22.19M | $19.67M | $20.30M | $22.57M | $18.07M | +12.8% |
| Tax provision | $5.14M | $3.99M | $4.72M | $5.21M | $4.29M | +28.7% |
| Net income | $17.05M | $15.68M | $15.58M | $17.36M | $13.78M | +8.7% |
| Net income to common | $17.05M | $15.68M | $15.58M | $17.36M | $13.78M | +8.7% |
| Basic EPS | 0.75 | 0.69 | 0.69 | 0.77 | 0.61 | +8.7% |
| Diluted EPS | 0.74 | 0.68 | 0.68 | 0.75 | 0.60 | +8.8% |
| EBIT | $23.49M | $20.97M | $21.60M | $23.87M | $19.37M | +12.0% |
| EBITDA | $26.15M | $23.59M | $24.20M | $26.48M | $22.02M | +10.8% |
| Basic shares | 22.86M | 22.80M | 22.71M | 22.66M | 22.61M | +0.2% |
| Diluted shares | 24.53M | 23.03M | 22.97M | 24.39M | 22.89M | +6.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.63M | $26.85M | $28.24M | $25.49M | $27.18M | -0.8% |
| Cash & short-term investments | $376.24M | $367.23M | $359.12M | $343.06M | $319.49M | +2.5% |
| Accounts receivable | $35.68M | $35.77M | $33.61M | $32.42M | $36.54M | -0.2% |
| Inventory | $57.94M | $57.77M | $58.25M | $58.93M | $57.46M | +0.3% |
| Total current assets | $488.30M | $477.82M | $468.23M | $452.02M | $430.13M | +2.2% |
| Property, plant & equipment | $49.59M | $48.38M | $42.76M | $42.50M | $41.87M | +2.5% |
| Goodwill & intangibles | $96.49M | $97.62M | $99.03M | $97.66M | $99.10M | -1.2% |
| Total assets | $640.55M | $629.53M | $615.69M | $598.07M | $577.59M | +1.8% |
| Total current liabilities | $29.93M | $33.37M | $36.32M | $33.29M | $30.82M | -10.3% |
| Long-term debt | $169.09M | $168.87M | $168.65M | $168.42M | $168.21M | +0.1% |
| Total debt | $190.25M | $189.81M | $185.59M | $185.63M | $185.89M | +0.2% |
| Total liabilities | $220.21M | $222.90M | $222.17M | $219.15M | $214.91M | -1.2% |
| Retained earnings | $206.02M | $194.68M | $184.72M | $173.67M | $160.84M | +5.8% |
| Shareholder equity | $420.34M | $406.62M | $393.52M | $378.92M | $362.69M | +3.4% |
| Working capital | $458.36M | $444.45M | $431.91M | $418.74M | $399.31M | +3.1% |
| Net tangible assets | $323.85M | $309.00M | $294.48M | $281.27M | $263.59M | +4.8% |
| Shares issued | 22.86M | 24.48M | 24.40M | 24.29M | 24.25M | -6.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $17.05M | $15.68M | $15.58M | $17.36M | $13.78M | +8.7% |
| Depreciation & amortisation | $2.66M | $2.62M | $2.60M | $2.61M | $2.65M | +1.5% |
| Stock-based compensation | $1.94M | $2.09M | $2.10M | $1.74M | $1.94M | -7.5% |
| Change in working capital | -$6.40M | -$6.25M | -$1.23M | $5.65M | $1.24M | -2.3% |
| Operating cash flow | $15.96M | $15.09M | $23.16M | $28.76M | $20.29M | +5.8% |
| Capital expenditure | -$2.31M | -$2.78M | -$1.78M | -$2.28M | -$1.34M | +16.9% |
| Investing cash flow | -$11.08M | -$13.12M | -$16.82M | -$27.45M | -$16.35M | +15.6% |
| Dividends paid | -$5.72M | -$5.71M | -$4.54M | -$4.54M | -$4.52M | -0.1% |
| Financing cash flow | -$5.05M | -$3.22M | -$3.59M | -$2.95M | -$2.76M | -56.9% |
| Free cash flow | $13.65M | $12.31M | $21.38M | $26.48M | $18.95M | +10.9% |
| End cash position | $26.63M | $26.85M | $28.24M | $25.49M | $27.18M | -0.8% |
Options analytics
Put / call volume
0.01
Call-heavy session
Put / call open interest
0.02
Positioning, not flow
Max pain
80.00
+1.2% from spot
ATM implied vol
33.0%
Nearest strike to spot
Skew (10% OTM)
+44.6%
Puts bid over calls
Call volume
122
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
85.00
475 contracts
Heaviest put OI
80.00
6 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.81 | 0.74 | -8.3% |
| Mar 2026 | 0.66 | 0.68 | +3.0% |
| Dec 2025 | 0.66 | 0.68 | +2.4% |
| Sep 2025 | 0.56 | 0.75 | +33.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.69 | 8 | $67.39M | +10.4% |
| Next quarter | 0.78 | 8 | $72.24M | +12.1% |
| Current year | 2.88 | 8 | $276.54M | +10.8% |
| Next year | 3.18 | 8 | $302.92M | +9.5% |
Analyst targets & ownership
Mean target$107.00
High target$132.00
Low target$81.00
Implied upside35.05%
Analyst count7
ConsensusBUY
Strong buy / Buy2 / 2
Hold4
Sell / Strong sell0 / 0
Held by insiders6.52%
Held by institutions103.94%
Institutions holding443
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
80.99
-2.18% from price
SMA 20
80.43
-1.72% from price
SMA 50
83.48
-5.30% from price
SMA 100
90.26
-12.22% from price
SMA 200
94.56
-16.40% from price
EMA 12
80.56
-1.65% from price
EMA 26
81.28
-2.52% from price
EMA 50
83.99
-5.67% from price
RSI (14)
41.9
Neutral
MACD (12,26,9)
-0.72
Hist 0.17
ATR (14)
2.04
2.59% of price
Realised vol 30D
20.1%
Annualised
Bollinger upper
82.85
20, 2σ
Bollinger lower
78.02
20, 2σ
50 / 200 cross
Death
83.48 vs 94.56
Trend bias
Below 200
-16.40%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.41
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
20.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.9%
Peak to trough
Max drawdown 5Y
-33.5%
Peak to trough
ATR 14
2.04
2.59% of price
Beta (reported)
0.47
5Y monthly, from filing
Short interest
Shares short
1.69M
Prior 1.61M
Change vs prior
+5.2%
Shorts adding
% of float
9.31%
Normal
% of shares out
7.40%
Against total outstanding
Days to cover
5.7
Crowded exit
Float
21.30M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 3, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 6, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 6, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 6, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 26, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Feb 26, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| Feb 26, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 26, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Feb 20, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Nov 7, 25 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Oct 15, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate$1.00 / yr
Forward yield1.23%
5-year avg yield0.87%
Payout ratio31.58%
Ex-dividend dateAug 20, 2026
Next pay dateSep 3, 2026
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-05
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-14
Periodic Financial Reports
10-K · 2026-02-26
Headlines
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off
StockStory · 19h ago
Is LeMaitre Vascular (LMAT) A Bargain Following Its 90 Day Pullback?
Simply Wall St. · 12d ago
LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run
Simply Wall St. · 13d ago
3 Small-Cap Stocks We Steer Clear Of
StockStory · 15d ago
2 Profitable Stocks to Target This Week and 1 We Ignore
StockStory · 16d ago
3 Out-of-Favor Stocks with Questionable Fundamentals
StockStory · 33d ago
PAHC or LMAT: Which Is the Better Value Stock Right Now?
Zacks · 35d ago
Speculative Rally Weighed on LeMaitre Vascular (LMAT)
Insider Monkey · 36d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.